Per Horn, General Partner at Hygeia Ventures
Per Horn
General Partner

Serial entrepreneur and life sciences investor with 18+ years across executive and non-executive roles in Biotech and HealthTech. Founded and led accelerator programmes, brings equity, IPO and deal-making experience, and serves as Expert Evaluator for Vinnova. Six years of EIT Health leadership. Based in Copenhagen.

220 companies personally engaged over 18+ years Serial entrepreneur & founded and led accelerator programmes Equity, IPOs, deal-making & fundraising — corporate & investment background Expert Evaluator — Vinnova Pharma/corporate partnerships Public market experience Exit & capital strategy 6 years EIT Health leadership
Christos Vaitsis, General Partner at Hygeia Ventures
Christos Vaitsis
General Partner

HealthTech investor with 12+ years at the intersection of European public innovation capital and private venture markets, based in Athens. Engaged with 218 companies across sourcing, screening, funding decisions, equity negotiation and portfolio governance. Scientific foundation in Health AI and clinical informatics. Ten years of EIT Health leadership across Stockholm, Vienna & Athens.

218 companies personally engaged over 12+ years European Health Investor Network co-founder European Commission Expert Evaluator — €100M+ proposals evaluated to date Co-founder of 20+ European Accelertion programs from idea to scale · Founder of first pan-European program connecting startups with EU biobanks Equity structuring & venture creation — 5 spinoffs created & equity negotiated Governed €10M+ HealthTech innovation portfolio — 11 companies MSc Karolinska Institutet · VC/PE Executive Education Harvard Business School 10 years EIT Health leadership
Appointment in progress
Senior Venture Partner
To Be Announced

Senior Venture Partner — Actively Recruiting. A senior VC operator with at least one documented HealthTech exit is being recruited to complete the fund management team. Brings: VC syndicate leadership, follow-on strategy, LP reporting, institutional governance. Compensation borne entirely by GPs — zero cost to fund capital. Appointment target: before first close, subject to LPAC approval.

Minimum one attributable HealthTech exit required with documented entry and exit valuations Demonstrated VC-to-VC syndicate leadership LP reporting experience Institutional fund management credentials. Appointment subject to LPAC approval
Combined Track Record

What the GPs bring to Fund I.

30+ Combined Years
438 Startups
Supported | Mentored | Advised
€102M Direct Funding Decisions
(EIC/HADEA Programs)
€535M Raised by Supported Companies

Capital raised figures reflect publicly reported lifetime funding of companies supported by the GPs through their institutional roles — not capital deployed by Hygeia Ventures Fund I, and not solely attributable to GP involvement.

Governance

Institutional discipline from day one.

Investment Committee

2 General Partners plus 1 independent member with quarterly portfolio review.

LPAC

Limited Partner Advisory Committee composed of major investors (commitments > €10M).

Key controls

Key-Person clause, clawback, annual audit, IPEV-compliant valuation.